Ginger L. Graham, Executive Advisor at AMYLIN PHARMACEUTICALS INC (AMLN), sold 20,000 shares at $49.50 ($1.0M) on 2007-08-06, disclosed to the SEC on 2007-08-07.
Scheduled sale ($1.0M) by Executive Advisor under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $49.50 | 10,000 | $495K | 49.5% |
| 2 | $50.51 | 10,000 | $505K | 50.5% |
| Total | $50.01 avg | 20,000 | $1.0M | 100% |
| Filing → |
| AMLN | SELL | 2007-08-08 | $1.2M | — | Filing → |